3-(1-Dimethylamino)ethyl)phenol Hydrochloride: A Key Pharmaceutical Intermediate
Essential building block for advanced pharmaceutical synthesis and neurodegenerative disease treatments.
Get a Quote & SampleProduct Core Value
3-(1-Dimethylamino)ethyl)phenol Hydrochloride
This compound is a vital component in the synthesis of pharmaceuticals, most notably Rivastigmine, a crucial medication for managing symptoms of Alzheimer's and Parkinson's diseases. Its high purity and well-defined chemical properties make it indispensable for reliable drug manufacturing processes.
- Leverage CAS 5441-61-2 for your Rivastigmine synthesis, ensuring a high-purity intermediate for efficacy.
- Discover the benefits of high purity pharmaceutical intermediates from China for your drug development pipeline.
- Explore the applications of advanced pharmaceutical intermediate manufacturing for critical drug production.
- Understand the role of continuous flow chemistry in pharmaceutical synthesis for efficient and consistent intermediate production.
Key Advantages
Enhanced Therapeutic Efficacy
As a key intermediate for Rivastigmine, this compound directly contributes to treatments for neurodegenerative conditions, underscoring its impact on patient well-being and the importance of high purity pharmaceutical intermediates.
Reliable Supply Chain
The robust production capabilities in China ensure a consistent and dependable supply of this essential CAS 5441-61-2 pharmaceutical intermediate, meeting global demand.
Quality and Purity
With a purity specification of ≥99%, this compound meets stringent industry standards, making it a trustworthy Rivastigmine synthesis building block.
Key Applications
Rivastigmine Synthesis
The primary application is as a critical intermediate in the multi-step production of Rivastigmine, a widely used cholinesterase inhibitor.
API Intermediate
Serves as a fundamental building block for Active Pharmaceutical Ingredients (APIs), enabling complex molecular constructions.
Pharmaceutical Development
Essential for research and development in pharmaceuticals, particularly for drugs targeting neurological disorders.
Fine Chemical Synthesis
Utilized in broader fine chemical synthesis where its specific chemical structure and properties are required.